Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Integrated wire carrier for electrode array
Optimization of packaging sizes
Process to extract quassinoids
Electronic devices with voice command and contextual data processing capabilities
Method of optimizing air mover performance characteristics to minimize temperature variations in a computing system enclosure
Method for drug screening and characterization by calcium flux
Method for producing interferon alpha 5
  Randomly Featured Patents
Apparatus for secure positioning over and around a steering wheel and steering column to prevent theft
Computer system having cooperating spring, gear tracks and geared dampers for allowing a drive housing to move between open and closed positions
Method and kit for the determination of cellular activation profiles
Flow control device
Data input/output system for gasoline stations
Multiple auction coordination method and system
Simple hinge unit capable of providing electrical connection in an electronic apparatus
Method for producing carbonyl fluoride
Pop-up sewer backup indicator